Day Trading Calls in india

Day Trading Calls is a best type of technical and fundamental based services provided by capitalstars company .This types of services gives us a lot of profit in stock market.

stock Market

The stock market is one of the most important sources for companies to raise money.

join stock cash services with us

You can avail Free Stock Tips for two days to test our accuracy and if satisfied you can join stock cash services with us.

CAPITALSTARS RESEARCH FORUM

We have always worked to provide a challenging and professional work environment helped them to provide the best stock tips to our trading fraternity which produces profit every day. our main motto is client satisfaction which is comfortable with our services.

Nifty Futures Tips

You can avail Free Nifty/Bank Nifty futures Tips for two days to test our accuracy and if satisfied you can join this service with Capital Stars.

flying bird

Tricks and Tips

Friday, 31 August 2018

MARKET WRAP-UP 31-Aug-2018



Closing Bell: Sensex ends flat, Nifty fails to hold 11,700 on Day 1 of September series
A weak rupee, higher crude oil prices along with selloff in midcaps were one of the major reasons behind the downtrend on the market. The Indian currency fell to an all-time, historic low of 71 to the US dollar, before settling around 70.88 to the dollar at the time of equity markets coming to a close.
Banks were the major laggards on Friday, led by losses in names such as Yes Bank. Another index heavyweight, Reliance Industries, fell around 3 percent, managed to weigh on equity benchmarks. The Bank Nifty was largely lower through the day, along with weakness among metals, auto and energy names. Traditional defensives, IT and pharmaceuticals were the major gainers through the session. However, last hour buying also helped PSU banks end in the green.
At the close of market hours, the Sensex closed down 45.03 points or 0.12% at 38645.07, while the Nifty was lower by 2.10 points or 0.02% at 11674.70. The market breadth is positive 1,423 shares advanced, against a decline of 1,234 shares, while 193 shares were unchanged.



HEADLINES OF THE DAY

JSW Energy vs. Tatas war intensifies over Prayagraj Power offer
Lupin gets USFDA nod for generic potassium chloride solution
Trump is said to back $200 bn China tariffs next week


The crucial resistance for Nifty spot is now seen at 11760 and above this 11860. Support for the immediate term is now placed at 11620 next support will be 11550.




Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647.

CORPORATE NEWS 31-Aug-2018



Tata Motors, Dr.Reddy's stocks climb after foreign brokerage views
Shares of Tata Motors climbed 3% on the BSE on Friday after foreign brokerage house Goldman Sachs maintained a 'neutral' call on the stock with a target price of Rs283 and a potential upside of 9%.
The company's management remains comfortable with an EBIT guidance of 4% for FY19, while cost reduction initiatives, better volumes, and moderation in incentives to support margin, Goldman Sachs said.

Trump is said to back $200 bn China tariffs next week
President Donald Trump wants to move ahead with the plan to impose tariffs on $200bn-worth Chinese imports as soon as a public-comment period concludes next week, according to six people familiar with the matter.
Asked to confirm the plan in an interview with Bloomberg News in the Oval Office on Thursday, Trump smiled and said it was “not totally wrong.” He also criticized the management of the yuan, saying China has devalued its currency in response to a recent slowdown in economic growth.

Lupin gets USFDA nod for generic potassium chloride solution
Pharma major Lupin has received approval for its potassium chloride oral solution USP, 20 mEq/15 mL (10%) and 40 mEq/15 mL (20%), from the United States Food and Drug Administration (USFDA). The approval is to market a generic version of Genus Lifesciences' Potassium Chloride Oral Solution USP, 20 mEq/15 mL (10%) and 40 mEq/15 mL (20%).
Potassium chloride oral solution USP, 20 mEq/15 mL (10%) and 40 mEq/15 mL (20%), had annual sales of approximately $184.95mn in the US (IQVIA MAT June 2018).

Dilip Builcon wins contract worth Rs1,698cr
Dilip Buildcon announced in a BSE filing that it has received (LoA) from the Maharashtra state Road Development corporation Ltd. for a new EPC project in the state of Maharashtra. The entire cost of the project is estimated to be Rs1,698cr.
“The project pertains to Construction of Access Controled Nagpur-Mumbai Super Communication Expressway (Maharashtra Samruddhi Mahamarg) in the state of Maharashtra on EPC mode. It is for a length of 45,645 kms from village Pathare to Village Sonari in district Nashik” added the company spokesperson in the press release to the exchanges on Thursday.

JSW Energy vs. Tatas war intensifies over Prayagraj Power offer
Generation, transmission and trading company JSW Energy has raised its bid to Rs6,200cr for acquiring a stake in debt-laden Prayagraj Power Generation. This revised offer was made in a dramatic fashion, especially since Tata Group’s Resurgent Power Ventures was already given the go-ahead, that is a letter of intent (LoI), to acquire a 75% stake in the embattled firm.
Reportedly, JSW Energy is ready to “sweeten the deal” further, even though it is outbidding Resurgent by a margin of over Rs200cr.
Incidentally, Resurgent Power, a JV between Tata Power and ICICI Venture established in 2016, is an investment platform that focuses on acquiring thermal and hydroelectric projects.



Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647.



Thursday, 30 August 2018

Nifty like to open. 31-Aug-2018




Indian Indices:                           Trends on SGX Nifty indicate a flat to negative opening for the broader index in India, a fall of 10 points or 0.09 percent. Nifty futures were trading around 11,749-level on the Singaporean Exchange.

Global Market:

·       Asian stocks bruised by Trump's trade war threats: MSCI's broadest index of Asia-Pacific shares outside Japan dropped 0.2 percent in early trade while Japan's Nikkei dropped 0.8 percent.

·        Wall Street extends rally, tech leads S&P, Nasdaq to record highs: The Dow Jones Industrial Average rose 60.55 points, or 0.23 percent, to 26,124.57, the S&P 500 gained 16.52 points, or 0.57 percent, to 2,914.04 and the Nasdaq Composite added 79.65 points, or 0.99 percent, to 8,109.69.




·       Major Headlines of the day:

·        Shares of Jet Airways cut some losses from its intraday fall of over 2.5 percent on Friday morning as investors turned wary of a probe into the airline’s financials..
·       Due to some profit booking in the last couple of days, the Nifty concluded the August series with a gain of 4.56 percent over the July expiry's close..


·         Trend in FII flows:The FIIs were Net Value of Rs 958.01 On NSE, BSE and MSEI while the DIIs were Net Value of  -1598.67 per the provisional figures.




Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647.

CS OPENING BELL:31-Aug-2018



NIFTY SPOT UP 27 @11705
SENSEX SPOT UP 85 @38778
BANK NIFTY FUTURES DOWN 16 @ 28204
HAPPY TRADING!

WWW.CAPITALSTARS.COM +917440449744

CS NIFTY FUTURES (SEP ) OVERVIEW
TREND BEARISH
RES2: 11810
RES 1:11740
SUP1:11600
SUP2:11530



CS BANK NIFTY FUTURES (SEP ) OVERVIEW

TREND BULLISH
RES 2: 28860
RES 1: 28600
SUP1: 28100
SUP2: 27920



Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647.

Closing Bell:30-Aug-2018



Closing Bell: Nifty ends August series below 11,700, Sensex ends flat; pharma, metals gain big

A good recovery in the last hour of trade helped D-Street cut big losses and end August series on a slightly better note. However, the Nifty managed to close below 11,700-mark.
A weak rupee weighed on indices through the day, with the Indian currency dropping to a fresh low of 70.8550. Analysts had attributed the fall to rising crude oil prices and month-end dollar buying by oil companies to pay these off.

Among sectors, FMCG, metals and pharma along with PSU banks were the top gainers, while auto, energy and Bank Nifty were the big laggards. In the broader markets, the Nifty Midcap index, too, ended over one-fifth of a percent higher.

At the close of market hours, the Sensex ended lower by 32.83 points or 0.08% at 38690.10, while the Nifty was down 12.20 points or 0.10% at 11679.70. The market breadth was positive as 1,441 shares advanced, against a decline of 1,255 shares, while 169 shares were unchanged.


HEADLINES OF THE DAY

TCS to buy back up to Rs7cr shares from Sept. 6-21
Cadila gets two final USFDA approvals
Laurus Labs gets USFDA nod for Metformin Hydrochloride Tablets USP


The crucial resistance for Nifty spot is now seen at 11760 and above this 11840. Support for the immediate term is now placed at 11620 next support will be 11550.



Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647.

CORPORATE NEWS 30-Aug-2013



ICICI Securities: Chanda Kochhar to face shareholders at AGM today
ICICI Bank’s beleaguered CEO Chanda Kochhar, who is on an indefinite leave pending a probe against her, will face ICICI Securities shareholders at their annual general meeting today. The shareholders will vote on her candidature as a Director at the AGM to be held in Mumbai. Incidentally, Kocchar is all set to retire from the ICICI Bank subsidiary ICICI Securities’ Board and had offered to be reappointed on the panel.
The embattled ICICI’s top boss is facing conflict of interest for clearing loans to Venugopal Dhoot-owned Videocon Group, which subsequently invested in Nupower Renewables, a firm owned by Kocchar’s husband Deepak Kochchar. Citing nepotism and misconduct, it is also suggested that Kochhar received financial favors from borrowers against loans sanctioned by ICICI bank. Moreover, these allegations are being probed by Sebi, CBI and the I-T department.

Cadila gets two final USFDA approvals
Cadila has said that it has received final USFDA approvals to market Gemfibrozil tablets (600 mg) and Aripiprazole Orally Disintegrating Tablets (10/15/20/30mg).
Gemfibrozil tablet is the generic equivalent to Pfizer’s Lopid which is isused to treat very high cholesterol and triglyceride levels in people with pancreatitis. There are about 11 approved generic ANDAs (Aurobindo, Sun Pharma, Teva, etc.) in this drug.

National Fertilizer gains 4% on signing MoA with RFCL
Shares of National Fertilizer (NFL) were trading 4% up in the afternoon session Thursday after the company inked a Memorandum of Agreement (MoA) with Ramagundam Fertilizers & Chemicals Limited (RFCL) to market RFCL's Products.
According to an agreement, National Fertilizer will market RFCL’s products including 12.71LMT urea, which will be produced by RFCL's Plant at Ramagundam. The company will market urea under its brand "Kisan".

Laurus Labs gets USFDA nod for Metformin Hydrochloride Tablets USP
Laurus Labs has received an approval from United States Food and Drug Administration (USFDA) for Metformin Hydrochloride Tablets USP 500mg, 850mg and 1000mg which are used for treatment of diabetes.
The product and API will be commercialized from company’s unit 2 located at APSEZ, Atchutapuram, Visakhapatnam, Andhra Pradesh, the company said in the filing.

TCS to buyback up to Rs7cr shares from Sept. 6-21
India’s largest software services firm Tata Consultancy Services is all set to buyback up to 7cr fully paid-up equity shares from Sept. 6th to 21st. This will reportedly be the Mumbai-headquartered company’s third buyback in 2yrs.
In a BSE filing, the company clarified that as per the Sebi’s regulations, the company will dispatch the letter of offer to eligible shareholders on or before September 4.
Tata Group’s investment holding firm reportedly plans to use the cash from the TCS buyback to fund investment programs of other group companies as they expand their business presence.



Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647.

Wednesday, 29 August 2018

CS OPENING BELL:30-Aug-2018



NIFTY SPOT DOWN 25@11667
SENSEX SPOT DOWN 52@38670
BANK NIFTY FUTURES DOWN 194@ 28056
HAPPY TRADING!

      WWW.CAPITALSTARS.COM  +917440449744

CS NIFTY FUTURES (JUNE ) OVERVIEW

TREND BEARISH
RES2: 11810
RES 1:11740
SUP1:11600
SUP2:11530 


CS BANK NIFTY FUTURES (JUNE ) OVERVIEW

TREND BEARISH
RES 2: 28860
RES 1: 28600
SUP1: 28100
SUP2: 27920 



Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647.

CORPORATE NEWS 29-Aug-2018


Bharti Airtel gets FDI approval to transfer 15% stake of Bharti Telemedia to Warburg Pincus affiliate
Bharti Airtel has received FDI approval from the Ministry of Information and Broadcasting to transfer 15% stake in subsidiary Bharti Telemedia to an affiliate of Warburg Pincus. The company made this announcement to the exchanges in a press note on Wednesday morning. The agreement was announced in December 2017.

Meanwhile, "the company is planning to launch 9,000 sites and 4,150 km of optic fibers in Rajasthan during FY19", the telecom major said in a press note on Tuesday after market hours. With the planned launch, the number of Airtel’s mobile sites in Rajasthan would go up by 29%.

Suven Life receives product patents in China, Eurasia
Suven Life has secured product patents in China and Eurasia for a new chemical entity, which treats disorders associated with neurodegenerative diseases. These patents are valid through 2034, the company said in a press statement on Wednesday.
“We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally,” says Venkat Jasti, CEO of Suven.

USFDA inspects Cadila subsidiary’s Vadodara manufacturing facility
Cadila Healthcare’s fully-owned subsidiary Liva Pharmaceuticals’ injectables manufacturing facility in Vadodara underwent a USFDA inspection from August 20, 2018 to August 28, 2018.
In a BSE filing, the company clarified that this was a product-specific pre-approval inspection. It added that the inspection would be concluded with five observations and that the company would respond to the USFDA within 15 days.

ADAG stocks shine; Reliance Infrastructure rises 3%
Shares of Anil Dhirubhai Ambani Group (ADAG) were up in today’s trade, with Reliance Infrastructure rising 3.63% as the company’s board met to consider and approve the transfer of its integrated Mumbai power business to Adani Transmission.

Jain Irrigation bags order worth Rs127cr; stock jumps 4%
Jain Irrigation Systems was awarded a $18.27mn (~Rs127cr) contract by Rwanda Agriculture Board (RAB), Kigali, Rwanda for irrigation and watershed development (1220 /1752 Ha) in Mahama Sector under Export Targeted Modern Irrigated Agriculture Projects in Rwanda.

The project will be executed near Rusumo (Rwanda — Tanzania border) The project will be financed by the EXIM Bank of India under Government of India Line of Credit program.


Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647.

Closing Bell: 29-Aug-2018

Closing Bell: Nifty gives up 11,700 a day before F&O expiry, Sensex down 173 points; midcaps outperform.

A sharp selloff in the last hour of trade weighed on equity benchmarks on Wednesday, with the Nifty giving up 11,700-mark. Weakness among giant index names such as Reliance Industries, HDFC Bank, and Infosys, among others, dragged the market lower as well.
Banks had a negative impact on the market, along with energy stocks, infra, IT and pharmaceutical names. However, PSU banks and metals tried to offset the losses, but bulls had the tide in their favor.
At the close of market hours, the Sensex closed 173.70 points or 0.45% lower at 38722.93, while the Nifty fell 46.60 points or 0.40% at 11691.90. The market breadth is negative as 1,275 shares advanced, 1,415 shares declined, while 172 shares were unchanged.
ONGC, SBI, Bajaj Finance and UPL are the top gainers, while Coal India, RIL and Power Grid have lost the most.


HEADLINES OF THE DAY

Indian rupee hits a fresh record low of 70.57 per dollar.
India may breach 3.3% fiscal deficit target as oil prices rise.


The crucial resistance for Nifty spot is now seen at 11750 and above this 11900 Support for the immediate term is now placed at 11550 next support will be 11350.




Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647.

Tuesday, 28 August 2018

CS OPENING BELL:29-Aug-2018


NIFTY SPOT DOWN 5@11732
SENSEX SPOT UP 3@38899
BANK NIFTY FUTURES UP 8@ 28396
HAPPY TRADING! 

CS NIFTY FUTURES (JUNE ) OVERVIEW

TREND BEARISH
RES2: 11810
RES 1:11740
SUP1:11600
SUP2:11530 

CS BANK NIFTY FUTURES (JUNE ) OVERVIEW

TREND BULLISH
RES 2: 28860
RES 1: 28600
SUP1: 28100
SUP2: 27920


Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647.